New Alzheimer's drug combo faces safety test
Disease control
Not yet recruiting
This study aims to check if a new drug combination called X/T+X-EC is safe and tolerable for people with Alzheimer's disease who are already being treated with the medication lecanemab. It will involve 60 participants aged 60-85 over 32 weeks. Participants will be randomly assign…
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC